These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30907187)

  • 1. Growth hormone co-treatment on controlled ovarian stimulation in normal ovarian response women can improve embryo quality.
    Liu X; Bai H; Xie J; Shi J
    Gynecol Endocrinol; 2019 Sep; 35(9):787-791. PubMed ID: 30907187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of
    Chen Y; Tao L; Lin Y; Li X; Ma C
    Gynecol Endocrinol; 2020 Nov; 36(11):955-958. PubMed ID: 32172647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone co-treatment in IVF/ICSI cycles in poor responders.
    Ob'edkova K; Kogan I; Krikheli I; Dzhemlikhanova L; Muller V; Mekina I; Lesik E; Komarova E; Mazilina M; Niauri D; Gzgzyan A; Aylamazyan E
    Gynecol Endocrinol; 2017; 33(sup1):15-17. PubMed ID: 29264990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study.
    Choe SA; Kim MJ; Lee HJ; Kim J; Chang EM; Kim JW; Park HM; Lyu SW; Lee WS; Yoon TK; Kim YS
    Arch Gynecol Obstet; 2018 Mar; 297(3):791-796. PubMed ID: 29264647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of growth hormone plus gonadotropins on controlled ovarian stimulation in infertile women of advanced age, poor responders, and previous in vitro fertilization failure patients.
    Ho YK; Lee TH; Lee CI; Cheng EH; Huang CC; Huang LS; Lee MS
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):806-810. PubMed ID: 29241924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF/ICSI cycles.
    Zhou C; Yang X; Wang Y; Xi J; Pan H; Wang M; Zhou Y; Xiao Y
    Hum Reprod; 2022 Jul; 37(8):1795-1805. PubMed ID: 35595223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial.
    Dong J; Wang Y; Chai WR; Hong QQ; Wang NL; Sun LH; Long H; Wang L; Tian H; Lyu QF; Lu XF; Chen QJ; Kuang YP
    BJOG; 2017 Jun; 124(7):1048-1055. PubMed ID: 28276192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer].
    Zhuang GL; Wong SX; Zhou CQ
    Zhonghua Fu Chan Ke Za Zhi; 1994 Aug; 29(8):471-4, 510. PubMed ID: 7835118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen valerate pretreatment with the antagonist protocol does not increase oocyte retrieval in patients with low ovarian response: a randomized controlled trial.
    Zhang S; Tang Y; Wang X; Zong Y; Li X; Cai S; Ma H; Guo H; Song J; Lin G; Lu G; Gong F
    Hum Reprod; 2022 Jun; 37(7):1431-1439. PubMed ID: 35460400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Follicular Phase Human Chorionic Gonadotropin Addition May Improve the Outcomes of
    Zhang C; Wu F; Wu Z; Sun B; Chen C; Qian W
    Front Endocrinol (Lausanne); 2021; 12():739773. PubMed ID: 34707571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic review and meta-analysis.
    Li XL; Wang L; Lv F; Huang XM; Wang LP; Pan Y; Zhang XM
    Medicine (Baltimore); 2017 Mar; 96(12):e6443. PubMed ID: 28328856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evidence of growth hormone for infertile women with diminished ovarian reserve undergoing IVF: a systematic review and meta-analysis.
    Lin G; Zhong X; Li S; Xu L
    Front Endocrinol (Lausanne); 2023; 14():1215755. PubMed ID: 38027219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone alleviates oxidative stress and improves the IVF outcomes of poor ovarian responders: a randomized controlled trial.
    Gong Y; Zhang K; Xiong D; Wei J; Tan H; Qin S
    Reprod Biol Endocrinol; 2020 Sep; 18(1):91. PubMed ID: 32891163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of low-dose hCG to rFSH during ovarian stimulation for IVF/ICSI: is it beneficial?
    Partsinevelos GA; Antonakopoulos N; Kallianidis K; Drakakis P; Anagnostou E; Bletsa R; Loutradis D
    Clin Exp Obstet Gynecol; 2016; 43(6):818-825. PubMed ID: 29944230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of growth hormone supplementation with ultrashort GnRH antagonist in IVF/ICSI for poor responders; randomized controlled trial.
    Mohammad EH; Abou El Serour AG; Mohamed EAH; Abbasy AH; Zaatar M; Rageh KA; Shafeek MM; Issak ER
    Taiwan J Obstet Gynecol; 2021 Jan; 60(1):51-55. PubMed ID: 33495008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of letrozole co-treatment during ovarian stimulation on oocyte yield, embryo development, and live birth rate in women with normal ovarian reserve: secondary outcomes from the RIOT trial.
    Bülow NS; Warzecha AK; Nielsen MV; Andersen CY; Holt MD; Petersen MR; Sopa N; Zedeler A; Englund AL; Pinborg A; Grøndahl ML; Skouby SO; Macklon NS
    Hum Reprod; 2023 Nov; 38(11):2154-2165. PubMed ID: 37699851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application value of tumor necrosis factor inhibitors in in vitro fertilization-embryo transfer in infertile women with polycystic ovary syndrome.
    Liang JX; Zhang Y; Xiao CH; Cao S; Tian Y; Wang NN; Liu C
    BMC Pregnancy Childbirth; 2023 Apr; 23(1):247. PubMed ID: 37055769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.